Peer Review History
| Original SubmissionMay 3, 2025 |
|---|
|
Dear Dr. Tadege, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Aug 14 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Abayeneh Girma Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. PLOS requires an ORCID iD for the corresponding author in Editorial Manager on papers submitted after December 6th, 2016. Please ensure that you have an ORCID iD and that it is validated in Editorial Manager. To do this, go to ‘Update my Information’ (in the upper left-hand corner of the main menu), and click on the Fetch/Validate link next to the ORCID field. This will take you to the ORCID site and allow you to create a new iD or authenticate a pre-existing iD in Editorial Manager. 3. We note that your Data Availability Statement is currently as follows: [data are all contained within the manuscript and/or Supporting Information files, enter the following: All relevant data are within the manuscript and its Supporting Information files.] Please confirm at this time whether or not your submission contains all raw data required to replicate the results of your study. Authors must share the “minimal data set” for their submission. PLOS defines the minimal data set to consist of the data required to replicate all study findings reported in the article, as well as related metadata and methods (https://journals.plos.org/plosone/s/data-availability#loc-minimal-data-set-definition). For example, authors should submit the following data: - The values behind the means, standard deviations and other measures reported; - The values used to build graphs; - The points extracted from images for analysis. Authors do not need to submit their entire data set if only a portion of the data was used in the reported study. If your submission does not contain these data, please either upload them as Supporting Information files or deposit them to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. For a list of recommended repositories, please see https://journals.plos.org/plosone/s/recommended-repositories. If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially sensitive information, data are owned by a third-party organization, etc.) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent. If data are owned by a third party, please indicate how others may request data access. Additional Editor Comments: A major revision is required. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? Reviewer #1: Yes Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: Yes Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: Yes Reviewer #2: No ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes Reviewer #2: No ********** Reviewer #1: The manuscript is well written, the methodology, results, statistical analysis and discussion were well presented. The manuscript is technically sound and data provided in the manuscript. The statistical analysis is appropriate. All findings were outlined in the manuscript. The manuscript is presented in a standard English. The authors should address the comments made on the manuscript. Reviewer #2: General comments The manuscript presents a well-conducted cross-sectional study on the prevalence, intensity, and risk factors of Schistosoma mansoni and soil-transmitted helminth (STH) infections among schoolchildren in Ethiopia, alongside an evaluation of the diagnostic performance of the Point-of-Care Circulating Cathodic Antigen (POC-CCA) test. The study addresses an important public health issue in a region where these infections are endemic. The methodology is robust, and the findings are relevant to ongoing control efforts. However, there are several areas where the manuscript could be improved to enhance clarity, accuracy, and impact. 1. Ethical considerations: The manuscript states that ethical clearance was obtained from Hawassa University, but the reference number provided (IRB/172/16) appears outdated (2016). Given that the study was conducted in 2024, clarification or updated ethical approval documentation is necessary. Again, the consent process is described, but it would be beneficial to explicitly state whether assent was obtained from all children, including those under 12, or only those aged 12 and above. 2. Data availability: The manuscript claims that "all relevant data are within the manuscript and its Supporting Information files," but no supplementary files are provided. The authors should either upload the supporting data or clarify where it can be accessed. 3. Diagnostic performance analysis: The comparison between POC-CCA and Kato-Katz is a key contribution, but the specificity of POC-CCA (79.6%) is notably low. The authors should discuss potential reasons for this (e.g., cross-reactivity, persistent antigens post-treatment) and implications for field use. Again, the McNemar’s test result (χ² = 52.3, p < 0.001) indicates significant disagreement between the two tests, but the discussion does not adequately address this. The authors should elaborate on the practical implications of this discrepancy. 4. Risk factor analysis: The association between STH infections and factors like latrine availability and handwashing is well-documented in the literature. The authors should contextualize their findings more critically, discussing how their results align with or diverge from previous studies in similar settings. Again, the multivariate analysis for S. mansoni risk factors is clear, but the odds ratios for some variables (e.g., swimming, irrigation) are high. The authors should consider potential confounding factors (e.g., frequency of water contact) that were not adjusted for. 5. Prevalence and intensity: The reported prevalence of S. mansoni (20.1% by Kato-Katz) is described as "moderate," but the WHO threshold for moderate prevalence is ≥10% and <50%. The authors should explicitly state how their findings align with WHO guidelines for mass drug administration (MDA). Again, the intensity classification (light, moderate, heavy) is based on WHO criteria, but the geometric mean egg count (139.39 EPG) suggests a skewed distribution. The authors should discuss whether this affects the interpretation of intensity. 6. Limitations: The cross-sectional design and purposive school selection are noted as limitations, but the authors should also address potential biases (e.g., seasonal variations in transmission, non-random sampling). Again, the use of a single stool sample for Kato-Katz may underestimate prevalence due to day-to-day variation in egg excretion. This should be discussed as a limitation. 7. Minor Comments: (i) Abstract: The abstract is comprehensive but could be more concise. The methods section, for example, includes unnecessary details (e.g., SPSS version). Again, the conclusion should avoid redundancy (e.g., "necessity for additional control measures" is repeated). (ii) Tables and Figures: Table 1 (infection intensity) is clear but could be merged with Table 2 (socio-demographic factors) to streamline the presentation. Again, Figure 3 (helminth distribution) is informative but would benefit from a clearer legend (e.g., full parasite names instead of abbreviations). (iii) Writing and Clarity: Some sentences are overly long or awkwardly phrased (e.g., "The absence of a latrine at home emerged as a prominent risk factor for STH infection"). Editing for conciseness would improve readability. Again, the abbreviation "STH" is used throughout but should be defined at first mention in the abstract and main text. (iv) References: References are generally appropriate, but some are outdated (e.g., WHO guidelines from 2011). The authors should cite more recent WHO publications (e.g., 2022 guidelines). Again, a few references are incomplete (e.g., "Weekly epidemiological record Relevé épidémiologique hebdomadaire" lacks volume/issue details). ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: Yes: Obiageli Josephine Nebe Reviewer #2: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step.
|
| Revision 1 |
|
Dear Dr. Tadege, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Oct 25 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Abayeneh Girma Academic Editor PLOS ONE Journal Requirements: If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author Reviewer #1: All comments have been addressed Reviewer #3: (No Response) Reviewer #4: (No Response) ********** 2. Is the manuscript technically sound, and do the data support the conclusions??> Reviewer #1: Yes Reviewer #3: Yes Reviewer #4: Partly ********** 3. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: Yes Reviewer #3: No Reviewer #4: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: Yes Reviewer #3: Yes Reviewer #4: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes Reviewer #3: Yes Reviewer #4: Yes ********** Reviewer #1: The authors have adequately addressed the comments raised previously, however there few comments that need to be clarified in the current review. I found the manuscript technically sound and have value for policy and public health practice. Reviewer #3: I advise the author(s) to take into account the following issues even if they made revisions to the text in response to the feedback and recommendations of earlier reviewers: 1. Uncorrected or Inaccurate Responses to Reviewers: Ethical approval reference still unclear despite E.C. explanation; conversion not standardly recognized without explicit note. Data availability statement contradictory: claims data in SI, but no files uploaded; "available upon request" violates PLOS policy. Raw data not publicly accessible; IRB restriction cited but not justified sufficiently for non-public sharing. No supplementary files provided despite mention of questionnaire and raw data. Use of McNemar’s test inappropriate for described analysis; original use of logistic regression more suitable, change unexplained. 2. New Comments/Questions to Improve Quality: Correct inconsistent verb tense usage (e.g., "data was analysed" → "data were analysed"). Clarify statistical methods: justify switch from logistic regression to McNemar’s test. Fix subject-verb agreement errors (e.g., "the results shows" → "the results show"). Provide DOI or repository link for raw data to comply with PLOS policy. Include full ethical approval document with date conversion proof as supplementary. Define assent process clearly for children under 12 in methods. Update all WHO references to 2022 guidelines and complete missing citation details. Reviewer #4: Major Comments 1. What is your main objective? This might result in major revision of the whole MS contents. a. To assess the prevalence of S. mansoni and STHs (POC-CCA is additional) b. To evaluate the diagnostic performance of KK vs POC-CCA (STH is additional) c. ??? 2. Your result part is highly fragmented or not well organized: needs reshuffling. 3. What is the relevance of your study 4. Your discussion is precise and not attractive for your readers Minor comments Title 1. What do you mean by short title? 2. Check affiliation 3 Abstract 1. A sentence but two different ideas ‘While S. mansoni infection leads to chronic illness and mortality, research on its intensity remains limited in the study area.’ 2. Write acronyms of Point of Care Circulating Cathodic Antigen Test (POC-CCA) it its first appearance (in background section). 3. Modify your language through your entire document (e.g. A school-based cross-sectional study was conducted among 477 school children from April to June 2024 in Tulla district, Sidama Region, Southern Ethiopia). 4. Modify: Urine samples were also collected from the study participants and tested using POC-CCA for the detection of Schistosoma antigens. 5. Other helminths included … seams meaningless?? 6. Avoid vague sentences: e.g. ‘Moderate S. mansoni and STH infection and poor hygiene practice underscore for additional control measures. 7. Your conclusion is not attractive. 8. Reconsider your key words (read about how to select key words). 9. Geneal comment: Critical language problems Introduction Background 1. Put references in [..]. 2. Paragraph 5 (line 106-111): It looks like you are talking about your own study 3. The last paragraph: It is the main objective of your study but not well structured, and I recommend re-write. Are you comfortable with ‘to evaluate the prevalence…’? Also check your language (S. mansoni, S. mansoni). Method 1. … among four governmental elementary school children (schools) 2. Add sample collection portion and clearly indicate how you collected stool and urine samples from your study participants. 3. Infection intensities: You did categories (light, moderate and heavy) only for S. mansoni? 4. What is the relationship between quality and sample collection time? 5. Data analysis: indicate your reference test and give details about your analysis. Results 1. I prefer if you put your results of diagnostics for S. mansoni and then to risk factors, STH,… 2. Table 1: move it under risk factors sub-title. 3. What is the importance of table 2? ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: Yes: Obiageli Josephine Nebe Reviewer #3: Yes: Alqeer Aliyo Reviewer #4: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org
|
| Revision 2 |
|
Assessment of Schistosoma mansoni and Soil-transmitted Helminth Infections and the Diagnostic Performance of the Circulating Cathodic Antigen Test among Schoolchildren in Tulla District, Sidama Region, Southern Ethiopia. PONE-D-25-23474R2 Dear Dr. Tadege, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact billing support . If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Abayeneh Girma Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author Reviewer #1: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions??> Reviewer #1: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes ********** Reviewer #1: The manuscript looks great and all comments made in the previous document addressed. Good effort, great work. ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: Yes: Obiageli Josephine Nebe **********
|
| Formally Accepted |
|
PONE-D-25-23474R2 PLOS ONE Dear Dr. Tadege, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Abayeneh Girma Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .